Bolt Biotherapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bolt Biotherapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2020 to 2023.
  • Bolt Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$15.2M, a 6.65% increase year-over-year.
  • Bolt Biotherapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$65.1M, a 8.71% increase year-over-year.
  • Bolt Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$69.2M, a 21.5% increase from 2022.
  • Bolt Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$88.1M, a 10.6% increase from 2021.
  • Bolt Biotherapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$98.6M, a 62.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$69.2M +$18.9M +21.5% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$88.1M +$10.5M +10.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$98.6M -$37.9M -62.3% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 -$60.7M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.